Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Therapie|March 1, 1995
[Drug-induced alopecia: review of the literature]M E Llau, R Viraben, J L MontastrucTherapie|September 1, 1995
[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]M E Llau, J M Senard, O Rascol, et al.Fundamental & Clinical Pharmacology|January 1, 1994
Drug-induced parkinsonism: a reviewJ L Montastruc, M E Llau, O Rascol, et al.La Revue Du Praticien|May 15, 1997
[Movement disorders of drug origin]J L Montastruc, M E Llau-Bousquet, J M Senard, et al.Revue Neurologique|November 1, 1994
[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]M E Llau, L Nguyen, J M Senard, et al.Therapie|March 10, 2000
[Undesirable effects of spa treatments: apropos of a systematic, prospective spa surveillance study at Bagnères-de-Bigorre]J L Montastruc, R Dutkiewicz, M E Llau-Bousquet-Melou, et al.Therapie|March 1, 1994
[Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992]M E Llau, C Damase-Michel, M Lapeyre-Mestre, et al.Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessmentG Durrieu, M E LLau, O Rascol, et al.Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 1, 1994
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogsJ L Montastruc, M Lapeyre-Mestre, M E Llau, et al.Clinical Neuropharmacology|October 1, 1996
A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patientsM E Llau, G Durrieu, M A Tran, et al.Pageof 2